Carcinoma: all 6,719 studies

Page 54 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.

• Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer MarginsCompletedNCT01872130
• TACE Plus Recombinant Human Adenovirus for Hepatocellular CarcinomaStatus unknownNCT01869088Phase 3
• Effect of Edaravone on Radiation-induced Temporal Lobe NecrosisCompletedNCT01865201Phase 2
• Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCCCompletedNCT01864850Phase 3
• Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular CarcinomaStatus unknownNCT01861912Phase 2/3
• A Phase I Study of iPS Cell Generation From Patients With COPDCompletedNCT01860898Not applicable
• Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular CarcinomaStatus unknownNCT01860222Not applicable
• Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm PatientStatus unknownNCT01858207Phase 2
• Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein InvasionWithdrawnNCT01857726Not applicable
• Study of BEZ235 as Monotherapy in Patients With Transitional Cell Carcinoma After Failure of Platinum Based ChemotherapyTerminatedNCT01856101Phase 2
• Second-line Treatment With Icotinib in Esophageal Carcinoma Patients With EGFR Overexpression (IHC 3+) or Positive FISHCompletedNCT01855854Phase 2
• Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree CancerTerminatedNCT01855724Phase 2
• Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell CarcinomaStatus unknownNCT01855451Phase 3
• Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPCStatus unknownNCT01854203Phase 2/3
• Stereotactic Body Radiation Therapy for Hepatocellular CarcinomaCompletedNCT01850667Phase 2
• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein InvasionCompletedNCT01850368Phase 2
• Hepatocellular Carcinoma Using Stereotactic Body RadiotherapyStatus unknownNCT01850316Not applicable
• Randomized Trial on Intraoperative Radiotherapy Full Dose Vs External RadiotherapyCompletedNCT01849133Not applicable
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck CancerCompletedNCT01847326Phase 1
• Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast CancerCompletedNCT01846091Phase 1
• Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial TractCompletedNCT01844947Phase 1
• Endobiliary RFA for Unresectable Malignant Biliary StricturesCompletedNCT01844245Not applicable
• Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal CanalTerminatedNCT01843452Phase 2
• Efficacy of MUCIPLIQ on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering From Oral CancerCompletedNCT01840436Not applicable
• A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of CancerCompletedNCT01840280
• Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in ChinaCompletedNCT01839630
• Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a StageStatus unknownNCT01838720Not applicable
• Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)CompletedNCT01837381Not applicable
• Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical CarcinomaCompletedNCT01836484
• P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.Status unknownNCT01834963Phase 2
• Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma PatientsCompletedNCT01834469Phase 1/2
• Tivozanib + Gemcitabine in Metastatic RCCWithdrawnNCT01834183Phase 2
• Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular CarcinomaCompletedNCT01833299Phase 3
• TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular CarcinomaStatus unknownNCT01833286Phase 3
• Possible New Therapy for Advanced CancerTerminatedNCT01832974Phase 1
• A Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Advanced/Metastatic RCC PatientsCompletedNCT01831973Phase 2
• Study of S-1 in Combination With Radiotherapy in Esophageal CancerCompletedNCT01831531Phase 2
• The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) StudyWithdrawnNCT01831037
• Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and NeckStatus unknownNCT01830556Phase 2
• Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)Status unknownNCT01830231Phase 2/3
• A Randomized, Controlled Phase III Trial of Sorafenib With or Without cTACE in Patients With Advanced HCCCompletedNCT01829035Phase 3
• Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE TherapyCompletedNCT01828762Not applicable
• Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial CarcinomaCompletedNCT01828736Phase 2
• Pathological Validation of Functional Imaging in Head and Neck Squamous Cell CarcinomaTerminatedNCT01827709Not applicable
• Squamous Cell Carcinoma Antigen Analysis at the University Hospital OstravaCompletedNCT01827423Not applicable
• Autologous Dendritic Cells in Treating Patients With Metastatic Kidney CancerCompletedNCT01826877Phase 1
• Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cmStatus unknownNCT01825824Phase 2
• Sunitinib® in Patients With Recurrent Ovarian Clear Cell CarcinomaCompletedNCT01824615Phase 2
• Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)CompletedNCT01822613Phase 1
• Study of DC-CIK to Treat NPCStatus unknownNCT01821495Phase 2
• A Study of DC-CIK to Treat Hepatocellular CarcinomaStatus unknownNCT01821482Phase 2
• A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)WithdrawnNCT01820312Phase 2
• Efficacy and Safety of TORS for SCCAActive, not recruitingNCT01819480Not applicable
• Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal MetastasesStatus unknownNCT01818713Phase 2
• The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRTStatus unknownNCT01817023Phase 3
• Direct Visual Fluorescence in Finding Oral Cancer in High-Risk Patients and Patients Undergoing Routine Dental CareCompletedNCT01816841Not applicable
• Vitamin D3 (Vit D3) Supplementation and T Cell Immunomodulation in Patients With Newly Diagnosed Operative Invasive Ductal Breast CarcinomaTerminatedNCT01816555Phase 1
• A Registry Study on Shenqifuzheng（a Chinese Medicine Injection）Used in Hospitals in ChinaStatus unknownNCT01812876
• Oral Rigosertib for Squamous Cell CarcinomaCompletedNCT01807546Phase 2
• A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)WithdrawnNCT01801163Phase 1
• A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With TemsirolimusCompletedNCT01798446Phase 2
• Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic PatientsCompletedNCT01798173Not applicable
• Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC).CompletedNCT01798160Phase 4
• Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).Status unknownNCT01798147Phase 2
• Intraoperative Imaging of Breast Cancer With Indocyanine GreenCompletedNCT01796041Early Phase 1
• Magnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast CancerWithdrawnNCT01791998Not applicable
• 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCCStatus unknownNCT01791387Phase 2
• Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using CatumaxomabTerminatedNCT01784900Phase 2
• Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01783171Phase 1
• Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal CarcinomaCompletedNCT01783158
• A Post Marketing Surveillance As Required By Philippine Food And Drug AdministrationWithdrawnNCT01781442
• Body Composition Analysis in Patients Undergoing ChemoembolizationCompletedNCT01777698
• Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular CarcinomaCompletedNCT01777594Phase 2
• Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?CompletedNCT01770002Not applicable
• Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular CarcinomaStatus unknownNCT01768741Not applicable
• Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast CancerCompletedNCT01764802Phase 2
• Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerCompletedNCT01764789Not applicable
• REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CTWithdrawnNCT01762592Phase 3
• Sorafenib Combined With Chemotherapy for Renal Collecting Duct CarcinomaCompletedNCT01762150Phase 2
• CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENTStatus unknownNCT01760811Phase 1/2
• Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular CarcinomaCompletedNCT01759901Not applicable
• Hybrid PET/MR in the Therapy of Cervical CancerCompletedNCT01759355
• Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell CarcinomaTerminatedNCT01758458Phase 1/2
• Broccoli Sprout Extract in Treating Patients With Breast CancerCompletedNCT01753908Early Phase 1
• Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous CarcinomaStatus unknownNCT01752205Phase 3
• CIK Treatment for HCC Patient Underwent Radical ResectionCompletedNCT01749865Phase 3
• Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular CarcinomaStatus unknownNCT01747642Phase 2/3
• Analysis of Body Composition in Patients With Hepatocellular Carcinoma in RadioablationWithdrawnNCT01744639Not applicable
• Role of Esophagectomy in Complete Responders to CCRTTerminatedNCT01740375Phase 3
• Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and NeckCompletedNCT01737008Phase 1
• Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid CarcinomaWithdrawnNCT01736878Phase 2
• Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal CarcinomaStatus unknownNCT01735409Phase 1/2
• Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)WithdrawnNCT01732432
• Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder CancerCompletedNCT01731652Phase 2
• Sequential Therapy in Metastatic Renal Cell CarinomaCompletedNCT01731158Phase 2
• ImmunoTEP for Patients With Medullary Thyroid Carcinoma.CompletedNCT01730638Phase 1/2
• ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEACompletedNCT01730612Phase 1/2
• Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast CancerWithdrawnNCT01729832Not applicable
• Sorafenib in Elderly mRCCCompletedNCT01728948
• Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyWithdrawnNCT01728480Phase 1

← Carcinoma overview